Clinical Laserthermia Systems AB (publ) (STO:CLS.B)
2.920
-0.030 (-1.02%)
Apr 24, 2025, 2:21 PM CET
Clinical Laserthermia Systems AB Company Description
Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden.
The company offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue.
It also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers provides multiple options to control treatment.
In addition, the company offers various gauge laser applicators, as well as provides temperature and treatment monitoring devices.
Clinical Laserthermia Systems AB (publ) was incorporated in 2006 and is headquartered in Lund, Sweden.
Clinical Laserthermia Systems AB (publ)
Country | Sweden |
Founded | 2006 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 17 |
CEO | Dan Mogren |
Contact Details
Address: Building 405 Lund, 223 81 Sweden | |
Phone | 46 46 15 21 00 |
Website | clinicallaser.se |
Stock Details
Ticker Symbol | CLS.B |
Exchange | Nasdaq Stockholm |
Share Class | Class B Shares |
Fiscal Year | January - December |
Reporting Currency | SEK |
ISIN Number | SE0002756130 |
SIC Code | 3845 |
Key Executives
Name | Position |
---|---|
Dan Johansson Mogren | Chief Executive Officer |
Hakan Rosqvist | Interim Chief Financial Officer |
Jimmy Johansson | Executive Vice President of Operations |
Cristina Pantaleone | Chief Technical Officer |
Liselotte Nilsson | Vice President of Marketing |